Suraksha Diagnostic Limited IPO: Issue date, price, and lot size

The Suraksha Diagnostic Limited IPO has generated significant buzz in the market, as it promises to offer investors an opportunity to participate in the growth story of one of India's prominent diagnostic service providers. 

Here’s a comprehensive look at what you need to know about the IPO, its details, and whether it aligns with your investment goals.

Suraksha Diagnostic Limited IPO details

The following table provides key details of the Suraksha Diagnostic Limited IPO investment, including the issue size, price band, and lot size.

Suraksha Diagnostic Limited IPO timeline

Here is the timeline for the IPO to keep track of important dates:

About Suraksha Diagnostic Limited

Incorporated in 2005, Suraksha Diagnostic Limited is a leading provider of pathology, radiology testing, and medical consultancy services. Headquartered in New Town, Rajarhat, Kolkata – 700 156, West Bengal, India, the company operates with:

• A central reference laboratory and 8 satellite laboratories.
• 215 customer touchpoints, including 49 diagnostic centres and 166 sample collection centres, as of June 30, 2024.

The company is a one-stop destination for medical consultations, housing 120 polyclinics with over 750 doctors across 44 diagnostic centres. Its services are supported by advanced technology platforms such as:

• Laboratory Information Management System (LIMS)
• Radiology Information System (RIS)
• Picture Archive Communication System (PACS)
• Enterprise Resource Planning System (ERP)

Suraksha Diagnostic also offers customised testing packages and vaccination services and uses cutting-edge tools like digital pathology and artificial intelligence to deliver efficient results.

Suraksha Diagnostic Limited's financials

Amount in ₹ crore

Suraksha Diagnostic Limited IPO highlights: Strengths

1. Strategic market position: Well-established presence in eastern and northeastern India, a region with significant growth potential for organised diagnostic chains.
2. Integrated services: Provides a comprehensive range of pathology, radiology, and medical consultancy services under one roof.
3. Technological advancement: Investments in modern systems like LIMS, RIS, and PACS ensure seamless operations and high-quality services.
4. Customer loyalty: Strong commitment to quality translates to high customer retention and individual consumer business share.
5. Experienced management: Backed by a team with deep industry knowledge and experience.

Suraksha Diagnostic Limited IPO highlights: Challenges

1. Geographical concentration: Heavy reliance on operations in eastern and northeastern India could limit diversification and expose the company to regional risks.
2. Competitive industry: Operates in a fragmented market with increasing competition from organised and unorganised players.
3. Regulatory risks: Being in the healthcare sector, the company is subject to stringent regulations and compliance requirements.

Suraksha Diagnostic Limited IPO GMP update

The Suraksha Diagnostic Limited IPO GMP (Grey Market Premium) reflects the sentiment of grey market traders ahead of the IPO's listing. GMP acts as an indicator of how the stock might perform on its listing day. Investors can monitor updates on GMP to make more informed decisions about their participation in the IPO.

Should you invest in the Suraksha Diagnostic Limited IPO?

Investors should consider the company’s strengths, including its integrated service offerings and technological edge, alongside its challenges, such as geographical concentration and industry competition. 

This upcoming IPO could be a promising opportunity for those looking to tap into the healthcare diagnostics sector's growth potential. However, it's crucial to evaluate your financial goals and risk appetite before making any investment decision.

FAQs

1. What is the lot size for the Suraksha Diagnostic Limited IPO?

The lot size for the IPO is 34 Shares.

2. When does the Suraksha Diagnostic Limited IPO open and close?

The IPO opens on Friday, November 29, 2024, and closes on Tuesday, December 3, 2024.

3. Where will the shares of Suraksha Diagnostic Limited be listed?

The shares will be listed on the NSE and BSE.

4. What are the key strengths of Suraksha Diagnostic Limited?

Key strengths include its integrated service offerings, technological infrastructure, and strong customer retention.

5. How can I apply for the Suraksha Diagnostic Limited IPO?

You can apply through ASBA (Application Supported by Blocked Amount) or online through your broker’s platform.